コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 a1 (microglia), COX-1 (microglia), and GFAP (astroglia).
2 r dense perisynaptic expression primarily on astroglia.
3 were purely via contact between T cells and astroglia.
4 e role of N-SMase in the activation of human astroglia.
5 d generation of proinflammatory molecules in astroglia.
6 nuclear factor-kappaB in Abeta1-42-activated astroglia.
7 hat the phenotype may be cell autonomous for astroglia.
8 the end feet and radial processes of Muller astroglia.
9 ion in primary microglia, but not in primary astroglia.
10 d NFkappaB were associated with this site in astroglia.
11 ructural characteristics of both neurons and astroglia.
12 ld, suggesting AQP4-dependent K(+) uptake by astroglia.
13 dendrocytes, whereas BCATm is the isoform in astroglia.
14 in human U373MG astroglial cells and primary astroglia.
15 mal models to be metabolized specifically in astroglia.
16 nduced the production of NO in human primary astroglia.
17 hat Tat is secreted from RSV-tat-transfected astroglia.
18 stochemistry for microglia, macrophages, and astroglia.
19 to the multitude of adaptive roles played by astroglia.
20 hat monensin also raises intracellular pH in astroglia.
21 (ADNF), a protein secreted by VIP-stimulated astroglia.
22 stributed glial fibrillary acidic protein-ir astroglia.
23 ynthesis by mobilizing [Ca2+]i in developing astroglia.
24 xamined, including fibroblasts, myeloma, and astroglia.
25 ivity in these cells indicates that they are astroglia.
26 ed abnormal gene expression profiles from DS astroglia.
27 synthase, and thrombospondins 1 and 2 in DS astroglia.
28 urce and metabolic function are regulated by astroglia.
29 rminals accumulate d-aspartate as quickly as astroglia.
30 nction of interneurons, oligodendrocytes and astroglia.
31 exity of calcium signaling mechanisms in CNS astroglia.
32 th the bacterial lipopolysaccharide (LPS) in astroglia.
33 ession of inducible NO synthase in activated astroglia.
34 ve intranuclear inclusions in neurons and in astroglia.
35 he substantia nigra but in the microglia and astroglia.
36 ting the selective uptake of angiogenin into astroglia.
37 n contributed to activation of microglia and astroglia.
38 nthase (CerS) 6 in monocytes/macrophages and astroglia.
39 nd resulted in fewer activated microglia and astroglia.
40 ls in the VZ/SVZ region are neurons, 30% are astroglia, 15% are nestin+ cells, with other cell types
41 fferent percentages of microglia (10-20%) or astroglia (40-50%) back to the neuron-enriched cultures
42 strocyte preparations indicate that cortical astroglia account for approximately one-third of the tot
44 of fluorescently labeled AQP4+/+ and AQP4-/- astroglia after implantation into mouse brains in which
46 low input resistance of electrically passive astroglia allows extracellular currents to pass through
47 n the human brain, SVZ cells including local astroglia also express EZH2, correlating with postnatal
48 hic GFAP(+)/vimentin(+)/nestin(+) "reactive" astroglia and also the plasticities and lineage relation
49 t targets: a neurotrophic effect mediated by astroglia and an anti-inflammatory effect mediated by th
50 nd post-synaptic compartments of neurons and astroglia and are a unique model for studying the synapt
51 water-selective channel that is expressed in astroglia and basolateral plasma membranes of epithelia
52 Non-neurogenic cell types, such as cortical astroglia and fibroblasts, can be directly converted int
53 s, especially mGluR5) in developing cortical astroglia and found that developmental arborization of a
54 pecified during mid-embryogenesis to produce astroglia and interneurons, switch their fate and genera
55 phagocytic cells (e.g. activated microglia, astroglia and macrophages) for the efficient removal of
56 nally secreted factor that is endocytosed by astroglia and mediates neuroprotection in paracrine.
57 resent experiments, we studied activation of astroglia and microglia after intraocular scrapie infect
58 xpression of Socs3 mRNA and protein in mouse astroglia and microglia in both a time- and dose-depende
59 e in the activation of brain-derived primary astroglia and microglia in prion disease and perhaps oth
61 onneuronal pathology in neocortex (activated astroglia and microglia) is consistent with findings in
62 pha was observed only in neurons, but not in astroglia and microglia, and it was contingent on the ac
63 s contained micro-opioid receptor-expressing astroglia and microglia, and since glia are the principa
64 hanges in the number and activation of brain astroglia and microglia, particularly in the region of t
65 ts induced strong COX-2 expression mainly in astroglia and microglia, whereas COX-1 expression was pr
68 ate/glutamine neurotransmitter cycle between astroglia and neurons (0.32 +/- 0.07 micromol x gm(-1) x
69 tmentalization of glucose metabolism between astroglia and neurons but indicate that the compartmenta
72 ies and functional disorders, affecting both astroglia and neurons with a pathogenesis that is only m
74 mma was unique in inducing Shh expression in astroglia and NSCs, while paradoxically suppressing Gli1
76 but each progenitor compartment produces new astroglia and oligodendroglia; the latter expand 10- to
77 but not A-SMase, decreased the activation of astroglia and protected neurons from fibrillar Abeta tox
78 ndings demonstrate heterogeneity of reactive astroglia and show that scar borders are formed by newly
79 awareness that synaptic plasticity involves astroglia and the extracellular matrix is revealing new
80 opriate targets, whereas Pax2(+) optic nerve astroglia and Vim(+) radial glia may aid in early axonal
81 the extrinsic factors (such as perisynaptic astroglia) and the intrinsic factors (such as core subce
82 neurons survived longer than either NPCs or astroglia, and a small proportion were alive until at le
83 es showed marked activation of microglia and astroglia, and cytokine profiling indicated that macroph
85 active sites in hippocampal pyramidal cells, astroglia, and in microglia within 72 h after a period o
86 rillary acidic proteins (GFAPs), a marker of astroglia, and interleukin-1beta (IL-1beta), a prototype
88 entiate into three neural lineages (neurons, astroglia, and oligodendrocytes) when cultured in differ
90 etained the size and pleomorphism of hominid astroglia, and propagated Ca2+ signals 3-fold faster tha
92 dentity of cells induced from Ink4a/Arf-null astroglia, and short hairpin RNA-mediated acute knockdow
93 eful for studying the heterogeneity of human astroglia, and the unique Olig2PC-Astros may constitute
94 molecules, such as NO, IL-1beta, and IL-6 in astroglia, and these responses were purely via contact b
95 ttern recognition receptors on microglia and astroglia, and trigger an innate immune response charact
103 ical evidence strongly suggests that resting astroglia are potential sources of nitric oxide--a power
105 ese results indicate that some microglia and astroglia arise from a precursor that is a normal consti
106 troglia, but the utilization of hPSC-derived astroglia as cell therapy for neurological diseases has
107 expression of mSOD1(G93A) in motoneurons and astroglia, as well as microglia, was required to produce
108 SCI, cell processes deriving from different astroglia associated into overlapping bundles that quant
109 yte precursor-correlated proneural toward an astroglia-associated gene expression pattern, manifest i
110 ssage in vitro, wild-type postnatal cortical astroglia become progressively resistant to Dlx2-induced
111 (14)C]lactate oxidation to (14)CO(2) only in astroglia but not in neurons, indicating a kinetic prefe
112 ibrillary acidic protein immunoreactivity in astroglia, but it was not colocalized with markers for o
114 t to volume regulation is provided by Muller astroglia, but the identity of their osmosensor is unkno
115 em cells (hPSCs) have been differentiated to astroglia, but the utilization of hPSC-derived astroglia
116 , it is apparent that both the activation of astroglia by Abeta and that the cytotoxicity of activate
117 neurons from cytotoxic effects of activated astroglia by antisense knockdown of N-SMase, but not aci
118 y corrects the pathological phenotypes of DS astroglia by specifically modulating the expression of S
119 owever, increases in Ca(2+) concentration in astroglia can also release other signalling molecules, m
121 ceptors (NMDARs), and it has been shown that astroglia can regulate their activation through Ca(2+)-d
123 trocyte-conditioned medium collected from DS astroglia causes toxicity to neurons, and fails to promo
129 e in cytokine response between microglia and astroglia correlated with 20-fold-higher levels of PrP e
130 that shape both short- and long-range neuro-astroglia coupling, as these are manifest in epilepsy ph
133 es, motoneuron-like NSC34 cells, and primary astroglia cultures as model systems, we here demonstrate
134 es but not in enriched neuron, microglia, or astroglia cultures nor in mixed neuron-astroglia culture
136 rected production of interleukin-6 (IL-6) by astroglia decreased overall neurogenesis by 63% in the h
138 he effect of kappa-agonists on the growth of astroglia derived from 1-2-day-old mouse cerebra was exa
140 ause we have reported that IL-1 can regulate astroglia-derived dopaminergic neurotrophic factors, it
141 ese Olig2PC-Astros differ substantially from astroglia differentiated from Olig2-negative hESC-derive
142 is a critical strategy for cytokine-induced astroglia differentiation and lineage-characteristic gen
144 at morphological activation of microglia and astroglia does not predict glial function, and that the
151 harvested from N-PPARgamma-KO mice, but not astroglia, exposed to ischemia in vitro demonstrated mor
152 found that rat Per1::luc and mouse Per2::luc astroglia express circadian rhythms with a genetically d
153 plastic neurons, giant cells, and dysplastic astroglia express high levels of pS6 and demonstrate alt
158 ifferentiation and maintenance of functional astroglia from human pluripotent stem cells in a chemica
159 thed by processes from individual developing astroglia from postnatal day (P) 14 to P26, when astrogl
160 fluence of ethanol on proliferation of human astroglia from the gray and white matter of adult tempor
161 ot express markers characteristic for mature astroglia (GFAP), oligodendroglia (CNPase), or neurons (
162 was carried out for 21 days to obtain either astroglia (>95% GFAP(+)) or a 1:5 mixed neuron/astroglia
164 s regulating the early fate specification of astroglia have been characterized, mechanisms regulating
166 sis that matrix proteins generated by mature astroglia impose temporal and spatial limitations on axo
168 dly upregulated by reactive and perivascular astroglia in areas of injury in MS lesions and during EA
172 on, probably occurring almost exclusively in astroglia in response to glutamate stimulation, followed
174 oach could potentially enlighten the role of astroglia in supporting brain glutamatergic activity and
175 leads to long-term changes in the density of astroglia in the brain regions involved in stress respon
177 control of the production of neurons versus astroglia in the developing hippocampus.Finally, we conf
178 of GLT1 in the cortex, but has no effect on astroglia in the hypothalamus, where non-VGluT1(+) synap
180 tly, pioneer RGC axons run among the Pax2(+) astroglia in the optic nerve and reach the superficial o
181 ion and phenotypic transformation of fibrous astroglia in white matter, and solely by phenotypic tran
182 jor cell types, neural precursors (nestin+), astroglia including radial glia (GFAP+, vimentin+), and
183 CO(2) and reduced lactate release mainly in astroglia, indicating that limitations in glucose and la
184 oducts released from activated primary human astroglia induced the activation of neutral sphingomyeli
187 ably disrupted the organization of elongated astroglia into scar borders, and caused a failure of ast
189 flammation involving activated microglia and astroglia is becoming a hallmark of many human diseases,
190 neurogenic competence of Ink4a/Arf-deficient astroglia is both greatly increased and does not diminis
193 hat soluble products released from activated astroglia kill neurons via N-SMase but not A-SMase.
196 tem; however, the specific contribution that astroglia make to neurodegeneration in human disease sta
197 itations in glucose and lactate oxidation by astroglia may be due to a greater balance of PDH toward
201 suggesting that high-level PrP expression on astroglia might be important for induction of certain cy
204 dysfunctional crosstalk between neurons and astroglia, neurons and innate immune system cells, as we
205 We subsequently demonstrated that it was the astroglia, not the microglia, that contributed to the ne
206 Cholinergic neurons and cerebral cortical astroglia, obtained separately from Ts16 mouse fetuses a
207 kI expression was found in testis, heart and astroglia of the qk(v)/qk(v) mice, suggesting that the r
210 concept that non-neuronal cells (microglia, astroglia, oligodendroglia) participate in the degenerat
214 ned medium (ACM) to examine the influence of astroglia on the regulation of GABAA receptor/Cl- channe
218 troglia (>95% GFAP(+)) or a 1:5 mixed neuron/astroglia population (beta-tubulin III(+)/GFAP(+)).
219 a produced only IL-12p40 and CXCL10, whereas astroglia produced these cytokines plus CCL2, CCL3, CCL5
220 onin may represent a mechanism through which astroglia provide these polyunsaturated fatty acids to n
225 conditions on hippocampal neurogenesis from astroglia, resulting in a robust increase in the number
228 ems, we demonstrated that microglia, but not astroglia, significantly enhanced the progression of MPT
229 pattern of cytokine release by microglia and astroglia similar to that induced by scrapie-infected br
230 We show that a small population of Gfap+ astroglia spans the midline of the zebrafish forebrain i
232 ast, phosphacan message was detected only in astroglia, such as the Golgi epithelial cells of the cer
233 ypertrophic, vimentin(+)/nestin(+), reactive astroglia that accumulated in spinal cord in this multip
234 2 in mice with conditional MeCP2 deletion in astroglia, these data support the hypothesis of an impor
236 nuclear inclusions were found in neurons and astroglia throughout the brain in cortical and subcortic
237 To specifically measure the contribution of astroglia to brain energy metabolism in humans, we used
238 ut the cortex; furthermore, the targeting of astroglia to dorsolateral cortex requires FGFr2 signalin
239 a into scar borders, and caused a failure of astroglia to surround inflammatory cells, resulting in i
240 t mice, suggesting that precise targeting of astroglia to the cortex has unexpected roles in axon gui
243 h 20-fold-higher levels of PrP expression in astroglia versus microglia, suggesting that high-level P
245 ial processes are abnormal and GFAP-positive astroglia were aberrantly present on the pial surface.
246 idermal growth factor (EGF)-stimulated human astroglia were arrested in G1 phase by IL-4, even though
248 sessing the morphological characteristics of astroglia were weakly immunoreactive for the endothelial
249 ein was expressed primarily in microglia and astroglia, whereas DR5 co-localized with neurons and OPC
250 fibrillary acidic protein-positive (GFAP(+)) astroglia, which also express immunoreactive nestin and
251 lutamate receptor 5 (mGluR5) signaling in S1 astroglia, which elicits spontaneous somatic Ca2+ transi
252 d the release of neurotrophic factor(s) from astroglia, which in turn was responsible for the neurotr
253 are formed by newly proliferated, elongated astroglia, which organize via STAT3-dependent mechanisms
254 ained in the adult, defining the optic nerve astroglia, which wrap the left and right nerves separate
255 s unidirectionally to induce RNA cleavage in astroglia, while the ALS-associated K40I mutant is also
256 CI consisted primarily of newly proliferated astroglia with elongated cell processes that surrounded
257 human glia were gap-junction-coupled to host astroglia, yet retained the size and pleomorphism of hom
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。